SK and CKD to lead new drug R&D in Korea.

Published: 2007-04-13 07:00:00

Updated: 2007-04-13 07:00:00

SK chemical and Chonkundang (CKD) have a majority number of new drugs on research in Korea according to "New drug R&D status of Korea" reported by Korea Drug Research Association.

The report unveiled that as of Jan. 31 this year the total 36 local pharmaceutical companies had 124 new drugs alr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK